Peter Cotton to HIV Infections
This is a "connection" page, showing publications Peter Cotton has written about HIV Infections.
Connection Strength
0.603
-
High-tech assault on HIV: gene therapy. JAMA. 1994 Oct 26; 272(16):1235-6.
Score: 0.069
-
Human rights as critical as condoms against HIV. JAMA. 1994 Sep 14; 272(10):758.
Score: 0.069
-
Trial halted after drug cuts maternal HIV transmission rate by two thirds. JAMA. 1994 Mar 16; 271(11):807.
Score: 0.066
-
Use of antiretroviral drugs in HIV disease declines following preliminary results from Concorde trial. JAMA. 1994 Feb 16; 271(7):488-9.
Score: 0.066
-
Infant AIDS prevention study finally gets going. JAMA. 1993 Oct 20; 270(15):1785.
Score: 0.065
-
Delayed trial of HIV immune globulin to protect infants of infected mothers is likely to resume. JAMA. 1993 Jan 06; 269(1):17.
Score: 0.061
-
Infants, science may lose as liability is blamed for company pullout from HIV prevention trial. JAMA. 1992 Oct 21; 268(15):1987, 1991-2.
Score: 0.060
-
Race joins host of unanswered questions on early HIV therapy. JAMA. 1991 Mar 06; 265(9):1065-6.
Score: 0.054
-
Controversy continues as experts ponder zidovudine's role in early HIV infection. JAMA. 1990 Mar 23-30; 263(12):1605.
Score: 0.050
-
Think tank helping to get HIV immune-restoration trials off the ground. JAMA. 1993 Dec 01; 270(21):2527-8.
Score: 0.016
-
Wider access provided to AIDS drugs with actions against HIV, CMV infections. JAMA. 1990 Oct 17; 264(15):1926.
Score: 0.013
-
Compliance problems, placebo effect cloud trials of topical analgesic. JAMA. 1990 Jul 04; 264(1):13-4.
Score: 0.013